Table 2.
Univariate Analysis of TP and SNPs in Olanzapine and Aprepitant Group
Polymorphism | Olanzapine Regimen (n (%)) | Aprepitant Regimen (n (%)) | |||
---|---|---|---|---|---|
Acute Phase | Delayed Phase | Acute Phase | Delayed Phase | ||
rs1045642 | TT | 17 (94.4) | 5 (27.8) | 6 (100.0) | 3 (50.0) |
Non-TT | 71 (93.4) | 48 (63.2) | 84 (92.3) | 52 (57.1) | |
P | 1.00 | 0.01 | 1.00 | 1.00 | |
rs2032582 | GG | 27 (93.1) | 17 (58.6) | 23 (88.5) | 9 (34.6) |
Non-GG | 61 (93.8) | 36 (55.4) | 67 (94.4) | 46 (64.8) | |
P | 0.27 | 0.77 | 0.38 | 0.01 |
Note: Only showed the significant data.